| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |